Medical/Pharmaceuticals

/C O R R E C T I O N -- World Meditation League (WML)/

In the news release, An Era Where Meditation Becomes a Quantifiable Achievement --Japan's First "Quantified Meditation Challenge", issued Oct. 7, 2025 by World Meditation League (WML) over PR Newswire, we are advised by the company that the photos have been updated. The complete, corrected releas...

2025-10-08 19:46 3056

Siemens Healthineers and National University Hospital Partner on Research to Advance Non-Invasive Liver Disease Diagnostics

* Partnership will evaluate advanced ultrasound technologies to improve early detection and monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease * Advancing ultrasound technologies that are safer, more accessible alternatives to invasive diagnostic procedures * Research le...

2025-10-08 11:15 1842

Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment

HMI-115 demonstrated statistically significant improvement in endometriosis pain The mean dysmenorrhea pain score was reduced by 42% The mean non-menstrual pelvic pain score was reduced by 52% Most of the patients had normal menstrual periods No typical peri-menopausal symptoms were reported Th...

2025-10-08 09:08 2473

New White Paper by APAC CVD Alliance and Deloitte Charts Path to Tackle Rising Heart Failure Burden in Asia-Pacific

* 32 million people in Asia-Pacific live with heart failure, and this number is rising fast. * New blueprint targets a 20% cut in hospitalisations and 15% boost in survival rates within 5 years. * Urgent call for early diagnosis, digital and community-based care, and sustainable financing t...

2025-10-08 09:00 1998

CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology

SHANGHAI, Oct. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of CT071 (an autologous CAR T-cell product targeting GPRC5D) for the treatment of relapsed/refractory mul...

2025-10-08 08:15 1752

ZEISS expands DORC portfolio and further strengthens digital footprint with improved workflow efficiency and digital visualization

Showcasing at AAO 2025: * NEW 510k CLEARANCE SUPPORTS MORE INFORMED DECISION MAKING & PATHOLOGY DETECTION: Showcasing optical coherence tomography angiography (OCT-A) with ZEISS CIRRUS AngioPlex® with noninvasive imaging of the retinal and choroidal vasculature; now with510k clearance and CE a...

2025-10-07 21:00 1629

Metabolon's Metabolomics Services Now Cited in More Than 4,000 Peer-Reviewed Publications

Metabolon's best-in-class metabolomics leadership accelerates as metabolomics becomes a standard inclusion in global multiomics studies MORRISVILLE, N.C., Oct. 7, 2025 /PRNewswire/ -- Metabolon

2025-10-07 21:00 1378

Celaid Therapeutics Raises JPY 1.055 Billion (USD 7.2 Million) in the First Close of its Series B Financing

TOKYO, Oct. 7, 2025 /PRNewswire/ -- Celaid Therapeutics Inc. ("Celaid"), today announced the successful completion of the 1st Close of its Series B financing round, raisingJPY 1.055 billion (USD 7.2 million) from venture capital firms and the Japan Agency for Medical Research and Development (AME...

2025-10-07 21:00 1795

Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program

SYDNEY, Oct. 7, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced an exclusive collaboration and in-licensing agreement (the "Agreement") with QIMR Berghofer for a first-in-class PD-L1 degrader program. The lead optimized...

2025-10-07 20:30 2318

Pantai Hospital Kuala Lumpur at Kuala Lumpur Standard Chartered Marathon 2025

From preventive screenings to Medic-On-The-Run, Pantai Hospital Kuala Lumpur brings healthcare beyond the hospital for Generation after Generation. KUALA LUMPUR, Malaysia, Oct. 7, 2025 /PRNewswire/ -- Health, like running, is a journey, not a destination. AsMalaysia's runners pushed their limits ...

2025-10-07 17:19 2069

Kadisco General Hospital and MindHYVE.ai™ Sign Strategic MoU to Transform Healthcare in Ethiopia with Agentic AI

ADDIS ABABA, Ethiopia, Oct. 7, 2025 /PRNewswire/ -- Kadisco General Hospital (KGH), one of Ethiopia's leading private healthcare institutions, and MindHYVE.ai™, a U.S.-based pioneer in agentic artificial intelligence (AI), have signed a Memorandum of Understanding (MoU) to launch an ambitious co...

2025-10-07 13:33 1483

Terumo Blood and Cell Technologies Honored with Corporate Excellence Award at the Asia Pacific Enterprise Awards 2025 Regional Edition

SINGAPORE, Oct. 7, 2025 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT) has been recognized with the Corporate Excellence Award at the Asia Pacific Enterprise Awards (APEA) 2025 Regional Editionorganized by Enterprise Asia, a testament to its unwavering commitment to innovation, ...

2025-10-07 13:25 1596

Japanese Innovation Comes to Thailand: Revolutionary Myopia Management Device Kubota Glass Debuts at ASEAN International Optics Fair Bangkok 2025

TOKYO, Oct. 7, 2025 /PRNewswire/ -- Leading Japanese pharmaceutical company Kubota Pharmaceutical Holdings Co., Ltd. will introduceThailand to its groundbreaking myopia management device,Kubota Glass, at Bangkok. Addressing Thailand's Growing...

2025-10-07 11:00 1891

Colebrook Bosson Saunders Celebrates 35 Years of Human-Centric Design

HONG KONG, Oct. 7, 2025 /PRNewswire/ -- Colebrook Bosson Saunders (CBS) , the leader in workplace ergonomics, is marking its 35th anniversary with the release of itsBrand Story eBook titled ...

2025-10-07 10:00 3661

Revolutionary Myopia Management Technology Expands Across Asia -- Kubota Glass Makes Global Debut at ASEAN International Optics Fair Bangkok 2025

TOKYO, Oct. 7, 2025 /PRNewswire/ -- Kubota Pharmaceutical Holdings Co., Ltd. (TSE: 4596) today announced that its groundbreaking myopia management device, Kubota Glass, will make its international debut at ASEAN International Optics Fair Bangkok 2025, taking place inBangkok, Thailand, from Octo...

2025-10-07 10:00 1848

UEG Week 2025: Microplastics found to change gut microbiome in first human-sample study

BERLIN, Oct. 7, 2025 /PRNewswire/ -- New research presented today at UEG Week 2025 shows that microplastics – plastic particles smaller than 5mm commonly found in the environment – can alter the human gut microbiome, with some changes resembling patterns linked to depression and colorectal cancer...

2025-10-07 06:01 1794

NCCN Guidelines Navigator for Breast Cancer Genetic Testing and Treatment Debuts During Breast Cancer Awareness Month

The National Comprehensive Cancer Network expands interactive library of evidence-based, expert consensus-driven cancer care guidance to now cover treatment for more than a dozen cancer types, along with hereditary risk assessment, featuring seamless integration with additional resources. PLYMOU...

2025-10-06 21:04 1458

Halia Therapeutics Strengthens Global Genomics Leadership with Appointment of Paul Jones as Chief Strategy Officer & GM, International Markets

New CSO & GM role underscores Halia's commitment to resilience-based therapeutic development and advances collaboration with the Department of Health –Abu Dhabi LEHI, Utah, Oct. 6, 2025 /PRNewswire/ -- Halia Therapeutics (The Genetic Resilience Company), a clinical-stage biopharmaceutical compa...

2025-10-06 20:15 1760

Olympus and W. L. Gore & Associates Enter into International Distribution Agreement to Expand the Olympus EndoTherapy Portfolio

CENTER VALLEY, Pa., and HAMBURG, Germany, Oct. 6, 2025 /PRNewswire/ -- Olympus Corporation, a global MedTech company committed to making people's lives healthier, safer and more fulfilling, has entered into an international distribution agreement with the medical products business of U.S.-basedW....

2025-10-06 15:00 1741

FDA Lifts Clinical Hold on NUZ-001

Highlights: * U.S. FDA lifts the Clinical Hold on NUZ‑001, Neurizon®'s lead investigational therapy for ALS * Clears the way for entry into the HEALEY ALS Platform Trial expected to commence in Q4 CY2025 * IND supported by robust preclinical safety data and comprehensive manufacturing and ...

2025-10-06 14:06 2553
1 ... 64656667686970 ... 647